VREX
Varex Imaging Corporation · Healthcare · Medical - Devices
Momentum inputs (comparable managers):
holder breadth +10.0% ·
share flow +30.0% ·
net new positions +9.1%
· formula
Broad accumulation: rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | -1 | 16.05K | $296,388 | n/a | −2 |
| Q2 2026 | 73 | +1 | 23.53M | $245.80M | +4 | −3 |
| Q1 2026 | 74 | -2 | 23.68M | $251.27M | +5 | −7 |
| Q4 2025 | 76 | +1 | 25.15M | $293.07M | +1 | n/a |
| Q3 2025 | 16 | 0 | 13.89M | $172.28M | +1 | −1 |
| Q2 2025 | 13 | -1 | 12.33M | $106.93M | +1 | −2 |
| Q1 2025 | 11 | -1 | 6.63M | $76.87M | n/a | −1 |
| Q4 2024 | 12 | 0 | 6.74M | $98.34M | +1 | −1 |
| Q3 2024 | 11 | +1 | 5.38M | $64.17M | +3 | −2 |
| Q2 2024 | 10 | n/a | 2.74M | $40.40M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 1.66M | New | $19.80M | 0.0% | New | 1 | SEC ↗ ×3 |
| 2 | Millennium Management ✦ | 1.01M | +69.2% | $12.06M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 929.00K | +0.5% | $11.08M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 4 | AQR Capital Management ✦ | 483.78K | +74.0% | $5.77M | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 5 | Citadel Advisors ✦ | 411.46K | +169.3% | $4.90M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 6 | D. E. Shaw & Co. ✦ | 380.73K | +353.1% | $4.54M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 7 | Renaissance Technologies ✦ | 236.90K | -1.0% | $2.82M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | Two Sigma Investments ✦ | 209.03K | -18.7% | $2.49M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | Point72 Asset Management ✦ | 34.80K | New | $414,816 | 0.0% | New | 1 | SEC ↗ |
| 10 | T. Rowe Price ✦ | 12.60K | +2.2% | $151,000 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Arrowstreet Capital ✦ | 12.42K | New | $148,082 | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Wellington Management | $19.80M | 0.0% |
| Point72 Asset Management | $414,816 | 0.0% |
| Arrowstreet Capital | $148,082 | 0.0% |
Exited
| Norges Bank | $2.40M | was 0.0% |
| Bridgewater Associates | $488,948 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 176 holders, 41.13M shares, $401.23M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Director · 8.12K sh · $150,076
Officer · 130.00K sh · $2.40M
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology